Lotus Award
The Lotus Award from Pershing Square Philanthropies funds innovative, high-impact ovarian cancer research to drive scientific breakthroughs and improve patient outcomes.
Funder: Pershing Square Philanthropies
Due Dates: February 2, 2026 (LOI) | February 1, 2027 (LOI)
Funding Amounts: $750,000 total ($250,000/year for 3 years; includes up to $25,000/year indirect costs)
Summary: Supports bold, innovative research projects in ovarian cancer, encouraging interdisciplinary collaboration to improve outcomes for women.
Key Information: Only one application per PI or collaborator per cycle; no full proposal stage, LOI is the sole submission.
Description
The Lotus Award, administered by Pershing Square Philanthropies, is dedicated to fostering transformative research in ovarian cancer—an underfunded and highly lethal gynecologic cancer. This program seeks to catalyze high-risk, high-reward projects with the potential to significantly advance the understanding, detection, prevention, or treatment of ovarian cancer. The award encourages applications from both established ovarian cancer researchers and investigators from other fields, provided those without direct ovarian cancer experience collaborate with an expert in the area. The initiative emphasizes innovation, interdisciplinary collaboration, and projects that may not be supported by traditional funding sources, aiming to shift paradigms and deliver real impact for women facing ovarian cancer.
